Chronic Oral Anticoagulation and Clinical Outcome in Hospitalized COVID-19 Patients

Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782.

CAS  Article  Google Scholar 

Song Y, Zhang M, Yin L, Wang K, Zhou Y, Zhou M, et al. COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2). Int J Antimicrob Agents. 2020;56(2):106080.

CAS  Article  Google Scholar 

Scudiero F, Pitì A, Keim R, Parodi G. Acute pulmonary embolism in COVID-19 patient: a case report of free-floating right heart thrombus successfully treated with fibrinolysis. Eur Heart J - Case Rep. 2020;5(1):ytaa388.

Article  Google Scholar 

Silverio A, Di Maio M, Ciccarelli M, Carrizzo A, Vecchione C, Galasso G. Timing of national lockdown and mortality in COVID-19: the Italian experience. Int J Infect Dis. 2020;100:193–5.

CAS  Article  Google Scholar 

Russo V, Piccinocchi G, Mandaliti V, Annunziata S, Cimmino G, Attena E, et al. Cardiovascular comorbidities and pharmacological treatments of COVID-19 patients not requiring hospitalization. Int J Environ Res Public Health. 2020;18(1):102.

Article  Google Scholar 

Russo V, Cardillo G, Viggiano GV, Mangiacapra S, Cavalli A, Fontanella A, et al. Thromboprofilaxys With Fondaparinux vs. Enoxaparin in hospitalized COVID-19 patients: a multicenter Italian observational study. Front Med. 2020;7:569567.

Article  Google Scholar 

Russo V, Rago A, Carbone A, Bottino R, Ammendola E, Della Cioppa N, et al. Atrial Fibrillation in COVID-19: from epidemiological association to pharmacological implications. J Cardiovasc Pharmacol. 2020;76(2):138–45.

CAS  Article  Google Scholar 

Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–81.

CAS  Article  Google Scholar 

Di Micco P, Russo V, Carannante N, Imparato M, Rodolfi S, Cardillo G, et al. Clotting factors in COVID-19: epidemiological association and prognostic values in different clinical presentations in an Italian cohort. J Clin Med. 2020;9(5):1371.

CAS  Article  Google Scholar 

Jose RJ, Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir Med. 2020;8(6):e46–7.

CAS  Article  Google Scholar 

Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–7.

CAS  Article  Google Scholar 

Di Micco P, Russo V, Carannante N, Imparato M, Cardillo G, Lodigiani C. Prognostic value of fibrinogen among COVID-19 patients admitted to an emergency department: an Italian cohort study. J Clin Med. 2020;9(12):4134.

Article  Google Scholar 

Scudiero F, Silverio A, Di Maio M, Russo V, Citro R, Personeni D, et al. Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcome. Thromb Res. 2021;198:34–9.

CAS  Article  Google Scholar 

Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63(3):364–74.

CAS  Article  Google Scholar 

Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol. 2020;75(23):2950–73.

CAS  Article  Google Scholar 

Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094–9.

CAS  Article  Google Scholar 

Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18(5):1023–6.

CAS  Article  Google Scholar 

Russo V, Cardillo G, Viggiano GV, Mangiacapra S, Cavalli A, Fontanella A, et al. Fondaparinux use in patients with COVID-19: a preliminary multicenter real-world experience. J Cardiovasc Pharmacol. 2020;76(4):369–71.

CAS  Article  Google Scholar 

ASH guidelines on use of anticoagulation in patients with COVID-19 - Hematology.org [Internet]. [cited 2020 Dec 20]. Available from: https://www.hematology.org:443/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/venous-thromboembolism-guidelines/ash-guidelines-on-use-of-anticoagulation-in-patients-with-covid-19

Flam B, Wintzell V, Ludvigsson JF, Mårtensson J, Pasternak B. Direct oral anticoagulant use and risk of severe COVID-19. J Intern Med. 2021;289(3):411–9.

CAS  Article  Google Scholar 

Denas G, Gennaro N, Ferroni E, Fedeli U, Lorenzoni G, Gregori D, et al. Reduction in all-cause mortality in COVID-19 patients on chronic oral anticoagulation: a population-based propensity score matched study. Int J Cardiol. 2021;329:266–269.

World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance. Pediatr Med Rodz. 2020;16(1):9–26.

Article  Google Scholar 

ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526–33.

Google Scholar 

Hindricks G, Potpara T, Dagres N. et al; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;42(5):373–498.

Article  Google Scholar 

Baumgartner H, Falk V, Bax JJ, et al. ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–91.

Article  Google Scholar 

Russo V, Di Maio M, Attena E, Silverio A, Scudiero F, Celentani D, et al. Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: a multicenter observational study. Pharmacol Res. 2020;159:104965.

CAS  Article  Google Scholar 

Canonico ME, Siciliano R, Scudiero F, Sanna GD, Parodi G. The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19. Eur Heart J Cardiovasc Pharmacother. 2020;6(4):262–264.

Ciceri F, Beretta L, Scandroglio AM, Colombo S, Landoni G, Ruggeri A, et al. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Crit Care Resusc. 2020;22(2):95–7.

PubMed  Google Scholar 

Rivera-Caravaca JM, Núñez-Gil IJ, Vivas D, Viana-Llamas MC, Uribarri A, Becerra-Muñoz VM, et al. Clinical profile and prognosis in patients on oral anticoagulation before admission for COVID-19. Eur J Clin Invest [Internet]. 2021 Jan [cited 2020 Dec 21];51(1). Available from: https://onlinelibrary.wiley.com/doi/10.1111/eci.13436

Tremblay D, van Gerwen M, Alsen M, Thibaud S, Kessler A, Venugopal S, et al. Impact of anticoagulation prior to COVID-19 infection: a propensity score–matched cohort study. Blood. 2020;136(1):144–7.

CAS  Article  Google Scholar 

Rossi R, Coppi F, Talarico M, Boriani G. Protective role of chronic treatment with direct oral anticoagulants in elderly patients affected by interstitial pneumonia in COVID-19 era. Eur J Intern Med. 2020;77:158–60.

CAS  Article  Google Scholar 

Sivaloganathan H, Ladikou EE, Chevassut T. COVID-19 mortality in patients on anticoagulants and antiplatelet agents. Br J Haematol [Internet]. 2020 Aug [cited 2020 Dec 21];190(4). Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16968

Brouns SH, Brüggemann R, Linkens AEMJH, Magdelijns FJ, Joosten H, Heijnen R, et al. Mortality and the use of antithrombotic therapies among nursing home residents with COVID-19. J Am Geriatr Soc. 2020;68(8):1647–52.

Article  Google Scholar 

Schiavone M, Gasperetti A, Mancone M, Curnis A, Mascioli G, Mitacchione G, et al. Oral anticoagulation and clinical outcomes in COVID-19: an Italian multicenter experience. Int J Cardiol. 2021;323:276–80.

Article  Google Scholar 

Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers D, Kant KM, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res. 2020;191:148–50.

CAS  Article  Google Scholar 

Hadid T, Kafri Z, Al-Katib A. Coagulation and anticoagulation in COVID-19. Blood Rev. 2020;47:100761. https://doi.org/10.1016/j.blre.2020.100761.

Scudiero F, Parodi G. Dual antiplatelet therapy in patients with acute coronary syndrome during COVID-19 pandemia: the right choice at right time. J Cardiovasc Med (Hagerstown). 2020;21(8):535–7.

CAS  Article  Google Scholar 

Josa-Laorden C, Crestelo-Vieitez A, García Andreu MDM, et al. Gender-based differences by age range in patients hospitalized with COVID-19: a Spanish observational cohort study. J Clin Med. 2021;10(5):899.

CAS  Article  Google Scholar 

Pijls BG, Jolani S, Atherley A, et al. Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies. BMJ Open. 2021;11(1):e044640.

Article  Google Scholar 

Kopel J, Perisetti A, Roghani A, Aziz M, Gajendran M, Goyal H. Racial and gender-based differences in COVID-19. Front Public Health. 2020;8:418.

Article  Google Scholar 

Pradhan A, Olsson PE. Sex differences in severity and mortality from COVID-19: Are males more vulnerable? Biol Sex Differ. 2020;11:53.

CAS  Article  Google Scholar 

Sama I, Ravera A, Santema B, et al. Circulating plasma concentrations of angiotenis-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Eur Heart J. 2020;41:1810–7.

CAS  Article  Google Scholar 

Silverio A, Di Maio M, Citro R, Esposito L, Iuliano G, Bellino M, et al. Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients. BMC Cardiovasc Disord. 2021;21(1):23.

CAS  Article  Google Scholar 

留言 (0)

沒有登入
gif